1. Home
  2. Companies
  3. 4DX
  4. Announcements

4Dmedical (ASX:4DX)

ASX announcement history & article coverage

36
Total announcements
(in last 3 months)
4
With article
32
No article
Article coverage
11%
Transparent by design. Announcments by 4Dmedical (ASX:4DX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

28 Aug 2026 · 03:17 pm AEST ASX Filing
Notification of Date of 2026 AGM
Notice of Meeting - Other
28 Aug 2026 · 11:04 am AEST ⚡ Price SensitiveMaterial ASX Filing
FY2026 Full year results
4DMedical reports FY26 growth with FDA clearance, US reimbursement, and $3B market expansion for CT:VQ™
Preliminary Final Report
90
4DMedical Accelerates CT:VQ™ Market Rollout with $3B US Opportunity and European Expansion Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026 Wrap Market Wrap - Week 35 (24 Aug -> 28 Aug) 2026 Wrap
28 Aug 2026 · 10:58 am AEST ⚡ Price Sensitive ASX Filing
Appendix 4E - Preliminary Final Report
Preliminary Final Report
14 Aug 2026 · 04:00 pm AEST ASX Filing
Application for quotation of securities - 4DX
Appendix 2A
13 Aug 2026 · 04:43 pm AEST ASX Filing
Cleansing Notice
Cleansing Notice
13 Aug 2026 · 04:37 pm AEST ASX Filing
Application for quotation of securities - 4DX
Appendix 2A
10 Aug 2026 · 04:44 pm AEST ASX Filing
Update - Proposed issue of securities - 4DX
Appendix 3B (Proposed issue of securities)

31 July 2026 · 04:46 pm AEST ASX Filing
Update - Proposed issue of securities - 4DX
Appendix 3B (Proposed issue of securities)
31 July 2026 · 10:13 am AEST ⚡ Price SensitiveMaterial ASX Filing
Quarterly Activity Report and Appendix 4C
4DMedical secures major US commercial deal, expands global footprint, and reports 23% revenue growth in FY26
Commitments Test Entity - Fourth Quarter Activity ReportCommitments Test Entity - Fourth Quarter Cashflow Report
90
4DMedical Expands US Footprint with SimonMed Deal and Posts 23% Revenue Growth Market Wrap - Week 31 (27 July -> 31 July) 2026 Wrap Healthcare Wrap - Week 31 (27 July -> 31 July) 2026 Wrap
20 July 2026 · 06:17 pm AEST ASX Filing
Change in substantial holding
Change in substantial holding
16 July 2026 · 12:31 pm AEST ⚡ Price Sensitive ASX Filing
US Bill directs VA to adopt 4D lung imaging
Trading Halt LiftedProgress Report
16 July 2026 · 10:45 am AEST ⚡ Price Sensitive ASX Filing
Trading Halt
Trading Halt
16 July 2026 · 10:00 am AEST ⚡ Price Sensitive ASX Filing
Pause in trade
4DMedical Limited trading halt announced
Notice Pending
40
10 July 2026 · 04:38 pm AEST ASX Filing
Becoming a substantial holder
Becoming a substantial holder
10 July 2026 · 03:30 pm AEST ASX Filing
Cleansing Notice
Cleansing Notice
10 July 2026 · 03:25 pm AEST ASX Filing
Application for quotation of securities - 4DX
Appendix 2A
10 July 2026 · 03:18 pm AEST ASX Filing
Application for quotation of securities - 4DX
Appendix 2A
6 July 2026 · 05:42 pm AEST ASX Filing
Ceasing to be a substantial holder
Ceasing to be a substantial holder
1 July 2026 · 02:52 pm AEST ASX Filing
Cleansing Notice
Cleansing Notice
1 July 2026 · 02:48 pm AEST ASX Filing
Application for quotation of securities - 4DX
Appendix 2A
1 July 2026 · 02:46 pm AEST ASX Filing
Application for quotation of securities - 4DX
Appendix 2A

26 June 2026 · 03:59 pm AEST ASX Filing
Change of Director's Interest Notice LB JL
Change of Director's Interest Notice
26 June 2026 · 03:55 pm AEST ASX Filing
Cleansing Notice
Cleansing Notice
26 June 2026 · 03:50 pm AEST ASX Filing
Application for quotation of securities - 4DX
Appendix 2A
26 June 2026 · 03:38 pm AEST ASX Filing
Application for quotation of securities - 4DX
Appendix 2A
26 June 2026 · 03:23 pm AEST ASX Filing
Proposed issue of securities - 4DX
Appendix 3B (Proposed issue of securities)
26 June 2026 · 03:14 pm AEST ASX Filing
Proposed issue of securities - 4DX
Appendix 3B (Proposed issue of securities)
26 June 2026 · 08:18 am AEST ⚡ Price SensitiveMaterial ASX Filing
4DMedical receives TGA approval for CTVQ in Australia
4DMedical secures TGA approval for CT:VQ™ in Australia enabling commercial rollout
Progress Report
85
4DMedical Secures TGA Nod for CT:VQ™ Unlocking Australia Rollout Market Wrap - Week 26 (22 June -> 26 June) 2026 Wrap Healthcare Wrap - Week 26 (22 June -> 26 June) 2026 Wrap
26 June 2026 · 08:11 am AEST ASX Filing
Becoming a substantial holder
Becoming a substantial holder
24 June 2026 · 08:22 am AEST ASX Filing
Becoming a substantial holder
Becoming a substantial holder
23 June 2026 · 09:28 am AEST ASX Filing
Change of Director's Interest Notice JS
Change of Director's Interest Notice
23 June 2026 · 08:14 am AEST ASX Filing
Ceasing to be a substantial holder
Ceasing to be a substantial holder
22 June 2026 · 08:11 am AEST ASX Filing
Becoming a substantial holder
Becoming a substantial holder
19 June 2026 · 05:59 pm AEST ASX Filing
Change in substantial holding
Change in substantial holding
12 June 2026 · 03:55 pm AEST ASX Filing
Application for quotation of securities - 4DX
Appendix 2A
2 June 2026 · 08:30 am AEST ⚡ Price SensitiveMaterial ASX Filing
4DMedical targets US$2.5B PE market entry for CTVQ
4DMedical launches CLEAR program targeting US$3B acute pulmonary embolism market with CT:VQ™
Web CastProgress Report
85
4DMedical Targets $3B US Pulmonary Embolism Market with New CLEAR Program Healthcare Wrap - Week 23 (1 June -> 5 June) 2026 Wrap